prof. dr. J.M. (Jan Maarten) van Dijl

Funding for research was obtained from AB Enzymes GmbH, ABON, China Scholarship Council (CSC), Conacyt Mexico, the De Cock-Hadders foundation, the European Commission (Biotechnology Programme, FP5, FP6, FP7, Horizon 2020, Horizon Europe, Marie Sklodowska Curie Actions), the European Science Foundation, DSM, DuPont Industrial Biosciences, EMBO, Fresenius Kabi iPSUM, the IAG-3 programme, NobleBio B.V., NWO-ALW, Stichting Technische Wetenschappen, SNN-EFRO, Top Institute Pharma, and the Ubbo Emmius foundation.